Synthetic DNA Vectors and Methods of Use
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/US2020/051507, filed Sep 18, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,324,839 | Synthetic DNA Vectors and Methods of Use In force · High confidence | Aldevron, LLC | In force | High confidence | ||
| US 11,602,569 | Synthetic DNA Vectors and Methods of Use In force · High confidence | Aldevron, LLC | In force | High confidence | ||
| US 11,684,680 | Synthetic DNA Vectors and Methods of Use In force · High confidence | Aldevron, LLC | In force | High confidence | ||
| US 11,766,490 | Synthetic DNA Vectors and Methods of Use In force · High confidence | Aldevron, LLC | In force | High confidence | ||
| Application 17/365,805 | Synthetic DNA Vectors and Methods of Use Abandoned Abandoned Sep 13, 2023 | Aldevron, LLC | Abandoned | Abandoned Sep 13, 2023 | ||
| Application 18/308,457 | Synthetic DNA Vectors and Methods of Use Pending Not granted | Aldevron, LLC | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Aldevron, LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.